Washington Trust Advisors’s Omnicell OMCL Stock Holding History

Washington Trust Advisors’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-254	Closed	-$46K	–	1016
2021 Q4	$46K	Buy	+254	New	+$44.1K	﹤0.01%	495

Other funds holding OMCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Washington Trust Advisors's OMCL Position: Q1 2022 in Review

Washington Trust Advisors sold out of Omnicell (OMCL) in Q1 2022, closing a stake of 254 shares — an estimated $46K sold.

Washington Trust Advisors first reported a position in OMCL in Q4 2021 and held it in 1 quarter. The position peaked at $46K in Q4 2021. 397 funds tracked by Wall St. Rank hold OMCL as of Q1 2022.

Washington Trust Advisors reported no remaining Omnicell position as of Q1 2022 after selling out during the quarter.
Washington Trust Advisors sold 254 Omnicell shares in Q1 2022, an estimated $46K.
Washington Trust Advisors first reported a position in Omnicell in Q4 2021 and held it in 1 quarter.
Washington Trust Advisors's Omnicell position peaked at $46K in Q4 2021.
397 funds tracked by Wall St. Rank held Omnicell as of Q1 2022.

Based on Washington Trust Advisors's 13F filing for Q1 2022, filed 5 May 2022.